The Educational Programmes on this page cover the following items:
HCC CONNECT Update from…
AASLD & ILCA 2017
HCC CONNECT Update from Seoul and Washington DC
HCC CONNECT has summarised the highlights of ILCA 2017 and AASLD 2017.
A CONNECT Update from Madrid
HCC CONNECT has summarised the highlights of ESMO September 2017 for you along with the other CONNECT groups.
HCC CONNECT Update from Amsterdam
HCC CONNECT has summarised the highlights of EASL 2017 for you.
Your clinical questions answered
Please submit your clinical topic for the next HCC CONNECT newsletter here.
What is the best approach for trans-arterial therapy in HCC?
Dr. Alexander Kim discusses the clinical question: What is the best approach for trans-arterial therapy in HCC?
Relevant papers discussed
SIRT or sorafenib in patients with locally advanced HCC: SARAH and SIRveNIB trials
Dr. Mohamed Bouattour from Hôpital Beaujon, APHP Clichy, France, discusses the SARAH and SIRveNIB trials in locally advanced HCC